Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2010, Vol. 06 ›› Issue (02): 115 -118. doi: 10.3877/cma.j.issn.1673-5250.2010.02.014

Original Article

Expression of Focal Adhesion Kinase in Epithelial Ovarian Cancer and Its Clinical Significance

Xing-li XU, Qing-lan JIA, Xiao-hua YAN, Xiang-ning ZHANG   

  1. Department of Obstetrics and Gynecology, Tengzhou Central People's Hospital, Tengzhou 277500, Shandong Province, China
  • Published:2010-04-01
Objective

To investigate the relationship between the expression of focal adhesion kinase (FAK) in human epithelial ovarian cancer (EOC) and clinicopathological features.

Methods

From June 2004 to December 2007, western-blot was used to detect the expression of focal adhesion kinase in 56 epithelial ovarian cancer with different clinical stages and different degrees of differentiation (research group). Research group was furthermore divided into following sub-groups: Lymph node metastasis sub-group (n=37), and non-lymph node metastasis sub-group (n=19); <50-year-old group (n=27) and ≥50-year-old group (n=29); T1, T2 sub-group (n=15) and T3, T4 sub-group (n=41) according to the clinical staging of malignant tumors made by International Federation of Gynecology and Obstetrics (FIGO) in 2000; grade Ⅰ sub-group (n=16), grade Ⅱ sub-group (n=25), and grade Ⅲ sub-group (n=15) according to the principle of pathological classification of malignant tumors; serous sub-group (n=30), mucinous sub-group (n=16), and endometrioid carcinoma sub-group (n=10) by different histological types. Another 22 cases with ovarian benign tumors were included to control group, including 14 cases with serous papillary cystadenoma and 8 cases with mucinous papillary cystadenoma. Informed consent was obtained from all participants. The positive expression rate of focal adhesion kinase between research group and control group was compared. The relationship between expression levels of focal adhesion kinase and clinicopathological characteristics were analyzed by χ2 test and Fisher exact test.

Results

The positive rate of focal adhesion kinase in research group was 76.9%(43/56) and in control group was 9.1%(2/22) (P<0.05). Significant difference was found in the positive expression rate of focal adhension kinase with different clinical staging (P<0.05). There was significant difference of different clinical stages between node metastasis sub-group and non-metastasis sub-group (P<0.05). There were no significant differences in the expression of focal adhesion kinase with different age of patients, pathologic grades and histologic types of tumors (P>0.05).

Conclusion

The expression level of focal adhesion kinase in ovarian cancer is higher than that of benign tumors. The positive expression rate of focal adhesion kinase has a close relationship with clinical staging and lymph node metastasis of epithelial ovarian cancer, but it has no relationship with age, pathological grades and histological types of tumors.

图1 黏着斑激酶在研究组和对照组中的表达(1:卵巢良性肿瘤;2:上皮性卵巢癌;3:卵巢良性肿瘤β-actin;4:上皮性卵巢癌β-actin)
图2 研究组及对照组中黏着斑激酶的表达及研究组中黏着斑激酶表达与临床病理特征间的关系(图2-A N:良性卵巢组织;T1~T4:T1~T4期上皮性卵巢癌。图2-B N:良性卵巢组织;T1~T3:卵巢上皮癌病理学分级Ⅰ~Ⅲ级)
1 Xie C, Li YL, Ying RT. Studies on the development of gemcitabine in epithelial ovarian cancer[J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2009, 5(5): 533-537. [谢聪,李玉玲,尹如铁,等.吉西它滨在上皮性卵巢癌中的研究发展[J/CD].中华妇幼临床医学杂志:电子版,2009, 5(5): 533-537.]
2 Huang D, Khoe M, Befekadu M, et al. Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways[J]. Am J Physiol Cell Physiol, 2007, 292 (4): 1339-1352.
3 Park H, Han I, Kwon HJ, et al. Focal adhesion kinase regulates syndecan-2- mediated tumorigenic activity of HT1080 fibrosarcoma cells[J]. Cancer Res, 2005, 65(21): 9899-9905.
4 Takahashi R, Sonoda Y, Ichikawa D, et al. Focal adhesion kinase determines the fate of death or survival of cells in response to TNF alpha in the presence of actinomycin D[J]. Biochim Biophys Acta, 2007, 1770(4): 518-526.
5 McLean GW, Komiyama NH, Serrels B, et al. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression [J]. Genes Dev, 2004, 18(24): 2998-3003.
6 White DE, Kurpios NA, Zuo D, et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction [J]. Cancer Cell, 2004, 6(2):159-170.
7 Carelli S, Zadra G, Vaira V, et al. Up-regulation of focal adhesion kinase in non-small cell lung cancer[J]. Lung Cancer, 2006, 53(3): 263-271.
8 Planas-Silva MD, Bruggeman RD, Grenko RT, et al. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor positive breast cancer[J]. Biochem Biophys Res Commun, 2006, 341(1): 73-81.
9 Wang AY, Fan XC, Lu Y, et al. Progress in the study of targets for anticancer drug[J]. J Pract Oncol, 2006, 20(4): 331-335. [王爱云,樊贤超,陆茵,等.抗肿瘤药物靶点研究进展[J].实用肿瘤学杂志,2006, 20(4): 331-335.]
10 Ding J, Ding JP, Li D, et al. Effect of gastrin on invasiveness of human colon cancer cells[J]. Chin J Oncol, 2005, 27(4): 213-215. [丁健,丁皆平,李丹,等.促胃液素对结肠癌细胞侵袭力的影响[J].中华肿瘤杂志,2005, 27(4): 213-215.]
11 Zhu CF, Gu Y, Wang B. The effects of blocked the expressions of focal adhesion kinase on the invasion behavior of hepatoma cells line MHCC97[J]. Liver, 2005, 10(3): 220-221. [朱晨芳,顾岩,王兵. FAK阻断对MHCC97肝癌细胞侵袭性的影响[J].肝脏,2005, 10(3): 220-221.]
12 Fang W, Wang XC, Wang LY, et al. Influence of focal adhesion kinase(FAK) on the biological behaviors of human hepatocellular carcinoma cells[J]. Chin J Oncol, 2001, 23(2): 125-127. [方祛,方新初,王丽影,等.黏着斑激酶对肝癌细胞生物学行为的影响[J].中华肿瘤杂志,2001, 23(2): 125-127.]
13 Halder J, Lin YG, Merritt WM, et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma[J].Cancer Res, 2007, 7(22): 10976-10983.
[1] Guo Sun, Yingdong Xie, Chaoli Xu, Bin Yang. Clinical value of a nomogram based on ultrasonic and clinical features for predicting central and lateral cervical lymph node metastases of thyroid papillary carcinoma[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 734-742.
[2] Xia Kang, Hao Tian, Jin Qian, Yuan Gao, Hongming Miao, Xiaowei Qi. Osteorin attenuates osteolysis during bone metastasis of cancers through inhibiting osteoclastogenesis[J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 329-339.
[3] Xingchen Liu, Juan Liu, Baobao Wei, Jie Liu, Hui Liu. Correlation analysis of abnormal expression of XIAP and XAF1 with ovarian cancer[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 419-427.
[4] Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[5] Yutao Yuan, Jinlin Xing, Kefei Xie, Kai Yin. Correlation between CT findings and BRAFV600E gene mutation and central lymph node metastasis in papillary thyroid carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 611-614.
[6] Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[7] Cheng Xu, Lulu Wang, Shaohua Wang. Application of eluent thyroglobulin in metastatic lymph nodes of thyroid papillary carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 701-704.
[8] Jian Chang, Feng Qiu, Yuqi Mao. Analysis of the relationship between ingestion inhibition factor-1 and liver metastasis after laparoscopic radical resection of colorectal cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 502-505.
[9] Xiaoyan Wang, You Xiao, Ge Xiao, Zhenquan Wang. CT characteristics and risk factors of lung metastasis in elderly patients with colorectal cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 506-509.
[10] Di Wang, Shaocheng Lyu, Jincan Huang. Pancreatic metastasis of lung adenocarcinoma with portal vein invasion: a case report[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 457-460.
[11] Hongjie Yang, Zhichun Zhang, Yi Sun. Study progress in the diagnosis of lymph node metastasis of rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 512-518.
[12] Yicheng Huang, Chen Lu, Sizheng Sun, Chunzhao Yu. Expression of liver-specific transcription factors FOXA2 in human stepwise metastatic colorectal carcinoma model and its significance[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 396-403.
[13] Qi Liu, Kai Zhang, Jiannan Li, Tongjun Liu. Current status and progress of biologic treatment for colorectal cancer liver metastases[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 415-419.
[14] Boyang Fan, Ning Wang, Qian Zhang, Guiyu Wang. The progress in research of molecular mechanism of circRNAs regulating colorectal cancer metastasis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(05): 426-430.
[15] Daijiang Liu, Junyan Jiang, Xiaoqiang Wan, Shaying Ma. Analysis of survival status and prognostic factors in patients with colorectal cancer with liver metastasis[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 284-288.
Viewed
Full text


Abstract